Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-20.19	25.43	31.87
Graham Fair Price	-58.33	75321.07	180753.87
PEG	4256.76	-0.23	< 0.005
Price/Book	21.08	0.64	0.53
Price/Cash Flow	272.21	156.32	42.00
Prices/Earnings	588.38	18.72	2.72
Price/Sales	18.22	0.51	0.43
Price/FCF	272.21	156.32	42.00
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	13.54	0.10	0.09
Operating Margin	60.77	0.04	0.03
ROA	-82.67	< 0.005	0.01
ROE	0.05	< 0.005	-82.41
ROIC	0.01	0.02	17.79
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.01	-62.55
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.34	0.63	87.41
EPS QOQ	5.22	-0.83	-84.20
FCF QOQ	-0.72	-0.68	5.86
Revenue QOQ	-0.03	0.01	-43.01
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	81.55	76.32	-6.42
Days Sales Outstanding (DSO)	63.85	68.83	7.80
Inventory Turnover	1.10	1.18	6.86
Debt/Capitalization	0.61	0.61	0.15
Quick Ratio	0.72	0.71	-0.41
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	172463.11	171355.06	-0.64
Cash	73925.92	66538.57	-9.99
Capex	-6760.49	-6367.62	5.81
Free Cash Flow	2181.12	704.97	-67.68
Revenue	213466.26	217232.95	1.76
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.35	1.30	-3.50
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	22.37	16.99	-24.02
Naive Interpretation	Member

06 - Financial Health · Weak

Rating